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Abstract
Cyclic 3′,5′-adenosine monophosphate (cAMP) response-element (CRE) binding protein (CREB)
is an important transcription factor that is differentially regulated in cells of various types. We
recently reported that RA rapidly activates CREB without using retinoic acid (RA) receptors RAR
and RXR in normal human tracheobronchial epithelial (NHTBE) cells. However, little is known
about RA’s role in the physiologic regulation of CREB expression in the early mucous
differentiation of NHTBE cells. Here, we report that RA upregulated CREB gene expression and
that using 5′-serial deletion promoter analysis and mutagenesis analyses, two Sp1-binding sites
located at nucleotides −217 and −150, which flank the transcription initiation site, were essential
for RA induction of CREB gene transcription. Furthermore, we found that CREs located at
nucleotides −119 and −98 contributed to basal promoter activity. Interestingly, RA also
upregulated Sp1 in a time- and dose-dependent manner. Knockdown of endogenous Sp1 using
small interfering RNA (siRNA) decreased RA-induced CREB gene expression. However, the
converse was not true: knockdown of CREB using CREB siRNA did not affect RA-induced Sp1
gene expression. We conclude that RA upregulates CREB gene expression during the early stage
of NHTBE cell differentiation and that RA-inducible Sp1 plays a major role in upregulating
human CREB gene expression. This result implies that cooperation of these two transcription
factors play a crucial role in mediating early events of normal mucous cell differentiation of
bronchial epithelial cells.
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Introduction
Retinoic acid (RA) exerts a profound effect on vertebrate development, cellular
differentiation, and homeostasis [1–4]. In addition, RA plays a pivotal role in the induction
and maintenance of mucociliary differentiation of airway epithelial cells [5–10]. In the
respiratory system, RA deficiency causes squamous metaplasia, and RA supplementation
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restores the normal mucous cell phenotype in cultured primary bronchial epithelial cells [7].
It has been well documented that the physiological effects of RAs are mediated through two
families of nuclear receptors (NRs), the RA receptor (RAR) and the retinoid X receptor
(RXR), which control transcription initiation by binding to RA-response elements (RAREs)
[1,11,12]. However, we recently demonstrated that RA rapidly activates CREB without
using RAR/RXR in normal human tracheobronchial epithelial (NHTBE) cells [13,14].
The cyclic 3′,5′-adenosine monophosphate (cAMP) response-element (CRE) binding protein
(CREB), a 43-kDa protein, belongs to a family of basic domain-leucine zipper (bZip)
transcription factors that contains activating transcription factor 1 (ATF1) and the CRE
modulator (CREM) [15,16]. CREB activates gene transcription by binding to regulatory
DNA elements in the promoter regions of genes with the consensus motif; binding has been
found to occur at an 8–base pair segment of the canonical CRE motif, 5′-TGACGTCA-3′,
and at other sequence variants (called CREs) [17–19]. Phosphorylation of CREB at serine
residue 133 (Ser-133) promotes recruitment of the transcriptional co-activator CREB-
binding protein (CBP)/p300 and/or the TATA box-binding protein-associated proteins (e.g.,
TAFII110) of the polymerase II complex to stimulate gene transcription [20–22].
CREB is widely distributed in most tissues and has an essential role in controlling cell
growth, differentiation, survival, and cell cycle progression and in determining the fate of
many cell types [23–27], as well as being a proto-oncogene in myeloid transformation [28].
The only mechanism reported to be involved in CREB expression is CREB phosphorylation
because CREB expression has been considered constitutive [29,30]. However, there is
increasing evidence that CREB gene expression is subject to dynamic regulation that varies
depending on the cell type. In primary rat Sertoli cells, activation of the cAMP pathway up-
regulates CREB expression via CREs present in the 5′ promoter region of the CREB gene
[31]. Regulation of CREB expression has also been demonstrated in neuronal cells in vivo
and in vitro [32–35]. However, these findings in Sertoli and neuronal cells are in marked
contrast to findings in certain other systems (e.g. CATA.a cells). Widnell et al [35] reported
that mRNA of CREB was down-regulated in CATH.a cells (a neural-derived cell line) by
activation of the cAMP pathway. Thus, it would appear that perturbation of the cAMP
pathway could exert opposite effects on CREB expression depending on the type of cells
involved.
Our previous studies showed that RA-activated CREB plays a critical role in the expression
of mucin genes, which are typical indicators of bronchial mucous cell differentiation
[13,14]. We also observed that CREB expression is very low in fully differentiated
metaplastic squamous bronchial epithelial cells. As it is evidenced that CREB can be
positively autoregulated [31], we hypothesized that RA-activated CREB induces CREB gene
expression in bronchial epithelial cells. To test the hypothesis, we determined the level of
CREB expression after RA treatment in NHTBE cells and analyzed the transcriptional
regulation mechanism using the upstream region of the human CREB gene. Interestingly, we
found that RA upregulates Sp1 expression and RA-inducible Sp1 contributes to the
upregulation of CREB, while basal level of CREB is autoregulated by CREB itself. These
data suggest cooperative role of these two transcription factors in regulation of CREB
expression during mucous cell differentiation of normal bronchial epithelial cells.
MATERIALS AND METHODS
Cell cultures and chemicals
NHTBE cells (Clonetics, San Diego, CA) were cultured by the air-liquid interface method as
described previously [5,7,13,36]. Briefly, second-passage NHTBE cells were seeded at a
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density of 1 × 105 cells onto 24-mm semipermeable membrane inserts (Transwell-Clear;
Corning, Inc., Acton, MA) and grown in serum-free culture medium supplemented with
growth factor and hormones. The air-liquid interface was initiated when the cultures were
confluent. All-trans RA, cycloheximide (CHX), and actinomycin D (ActD) (Sigma-Aldrich,
St. Louis, MO) were dissolved in DMSO. Ro 61-8431 (pan RAR antagonist) and Ro
26-5405 (pan RXR antagonist) were kindly provided by Roche Bioscience (Palo Alto, CA).
All cells were maintained at 37°C in an incubator containing 5% CO2.
Quantitative Real-time Polymerase Chain Reaction (QRT-PCR) and Conventional Reverse
Transcription PCR (RT-PCR) Analyses
Total RNA was extracted from NHTBE cells cultured in the absence or presence of RA (1
μM) for specific times and concentrated by using RNeasy mini-kits (Qiagen, Valencia, CA).
The RT reaction was performed using 1 μg of total RNA that was reverse-transcribed into
cDNA using a random hexamer primer (GeneAmp RNA PCR core kit; Applied Biosystems,
Foster City, CA) according to the manufacturer’s instructions. All primer sets produced
amplicons of expected sizes and sequences. For the quantitative analysis of mRNA
expression, the iCycler thermal cycler (Bio-Rad Laboratories, Inc., Rodeo, CA) was used
with the DNA binding dye SYBR green (Applied Biosystems-Perkin-Elmer Corp., San
Mateo, CA). The PCR cycling conditions for CREB expression were 95°C for 5 min
followed by 40 cycles at 95°C for 30 s and 60°C for 1 min. Initial PCR conditions for Sp1
expression were 95°C for 5 min followed by 40 cycles at 95°C, 55°C, and 72°C for 30 s
each. PCR for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) labeled with
VIC dye (Applied Biosystems) was done as an endogenous control. Primer sequences were
as follows: CREB sense, 5′-ACTGTAACGGTGCCAACTCC-3′ and antisense, 5′-
GAATGGTAGTACCCGGCTGA-3′. Human Sp1 primer sets were purchased from
SuperArray Biosciences (Frederick, MD). For conventional RT-PCR, total RNA was
extracted and then reverse transcribed into cDNA using a random hexamer primer. The
conditions for PCR were 30 cycles at 95°C, 55°C, and 68°C for 30 s each. PCR for β-actin
(Ambion, Inc., Austin, TX) was done as an internal control. Sp1 primer sequences were used
in QRT-PCR. Other primer sequences were as follows: CREB sense, 5′-
ACCATGGAATCTGGAGCCGAGAAC-3′ and antisense, 5′-
CTGTAGGAAGGCCTCCTTGAAAGA-3′, and RARβ sense, 5′-
AGCCTACGTGCCAAAAAAGG-3′ and antisense, 5′-
TCTAGGTGTGGAGGCAAATGG-3′. PCR products were then separated in a 2% agarose
DNA gel and stained with ethidium bromide.
Cloning of the Human CREB Promoter and Construction of Chimeric Luciferase Reporter
Plasmid
The bacterial artificial chromosome (BAC) clone (RPCI-11.C 17I6; Invitrogen Corporation,
Carlsbad, CA) was used to clone the human CREB promoter region. PCR was performed to
amplify the 5′-flanking regions of the CREB gene by using the human BAC DNA as the
template. The primers used to generate different promoter deletion plasmids were as
follows: forward, 5′-GAGGAGCTCACGGGTTGAGTTTGAAATGC-3′, 5′-
GAGGAGCTCGCCGTCCTGAGAGACCTCTG-3′, 5′-
GAGGAGCTCGCATGCTCCGCTGGCG-3′, 5′-
GAGGAGCTCCCGCTGCCGGCTTTACC-3′, 5′-
GAGGAGCTCAAGGTCTTCGGCAAGTTCC-3′, 5′-
GAGGAGCTCTAGCTCGGCTGTTTCCGT-3′, 5′-
GAGGAGCTCTGGCTGCGGCTCCTCAGT-3′, 5′-
GAGGAGCTCCGGAGTGTTGGTGAGTGACG-3′; and reverse, 5′-
GAGGCTAGCTTCTCTCCCCCACGTAACAC-3′. Primers were designed to contain SacI
or NheI restriction sites so that the resulting PCR-amplified fragments could be cloned into
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the multicloning sites upstream of the luciferase reporter gene in the pGL3-basic vector
(Promega Corporation, Madison, WI).
Site-directed mutations of the human CREB promoter were made in the context of
−321/−70 CREB-LUC, using the Quikchange site-directed mutagenesis kit (Stratagene, La
Jolla, CA). The oligomers used to introduce multiple point mutations were: CRE1, 5′-
GGAGGTGTAGTTTCTCGAGGTGTGTTACGTG-3′; CRE2, 5′-
TGTTGGTGAGTCTCGAGGCGGAGGTGTA-3′; CRE1+2, 5′-
GTTGGTGAGTCTCGAGGCGGAGGTGTAGTTTCTCGAGGTGTGTTAC-3′; Sp1-1, 5′-
TGTGGCCCGGGCCCCTGGGAGAAGCG-3′; and Sp1-2, 5′-
CTCGGCACTGGGCCCCGCTGGCTGGCT-3′, where boldface, underlined type indicates
a mutation [37]. To generate the Sp1-1+Sp1-2 mutant, the Sp1-1 and Sp1-2 primers were
used in combination. All constructs were confirmed by DNA sequencing.
Transfection and Luciferase Assays
For the luciferase assay, NHTBE cells were plated in 12-well culture plates at a density of 1
× 104 cells/well. Cells were grown in BEGM (bronchial epithelial growth medium) without
RA. When the cells reached 80% confluence, they were subjected to transient transfection
with 0.5 μg of plasmid DNA with FuGENE 6 transfection reagent (Roche Diagnostics,
Indianapolis, IN), which was performed according to the manufacturer’s instructions. To
normalize the transfection efficiencies of the various luciferase constructs, the phRL-CMV
plasmid containing the Renilla luciferase gene was co-transfected into the cells in a molar
ratio of 1:50 (phRL-CMV: pGL3). Four hours after transfection, medium was replaced, and
the cells were treated with RA. The cultures were maintained for an additional 48 h. CREB
promoter activity was determined by measuring firefly luciferase activity, and Renilla
luciferase activities were measured sequentially with a dual-luciferase reporter assay system
(Promega Corporation) according to the manufacturer’s instructions; the Lumant LB 9507
luminometer (EG & G Berthold, Bad Wildbad, Germany) was used to make the
measurements.
EMSA
To assess CREB’s DNA binding activity, we performed EMSA as described previously
[13,38], with necessary modifications. Briefly, nuclear proteins from RA-treated or
untreated cells were prepared and stored at −80°C. For EMSA, oligonucleotide-
corresponding sequences were as follows: Sp1-1, 5′-
TGTGGCCCGGGCGGCTGGGAGAAGCG-3′, Sp1-2, 5′-
CTCGGCACTGGGCGGCGCTGGCTGGCT-3′, CRE1, 5′-
GGAGGTGTAGTTTGACGCGGTGTGTTACGTG-3′, and CRE2, 5′-
TGTTGGTGAGTGACGCGGCGGAGGTGTA-3′. These oligonucleotides were annealed
and end-labeled with [γ-32P]ATP using T4 polynucleotidekinase. Ten micrograms of
nuclear extract was incubated at room temperature for 30 min with the 32P-labeled CRE
probe in binding buffer (20% glycerol, 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250
mM NaCl,50 mM Tris-Cl [pH 7.5], and 0.25 mg/ml poly[dI-dC]). DNA-nuclear protein
complexes were separated from the DNA probe by electrophoresis through 5%
nondenaturing polyacrylamide gels in 0.5× Tris borate EDTA (TBE) buffer. For supershift
analysis, nuclear extracts were incubated with anti-CREB and anti-Sp1 antibodies and then
incubated with oligonucleotide probes for 30 min at 37°C. The complex was then analyzed
by EMSA. Antibodies against pre-immune serum were included as negative controls. The
DNA-protein complexes were resolved by electrophoresis in 5% nondenaturing
polyacrylamide gels in0.5× TBE (1× TBE: 25 mM Tris base, 25 mM boric acid, and 0.5 mM
EDTA). Gels were dried and autoradiographed at −80°C. All EMSAs were repeated three
times, and consistent results were obtained.
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ChIP Analyses
ChIP assays were performed as described elsewhere [39,40]. Briefly, NHTBE cells were
activated with RA for 4, 8, 24, or 48 h and then cross-linked by reaction with 1%
formaldehyde for 10 min at 37°C. The cells were then washed with cold phosphate-buffered
saline (PBS). The cell pellet was resuspended in lysis buffer (1% SDS, 100 mM NaCl, 50
mM Tris-HCl [pH 8.1], and 5 mM EDTA) and then sonicated to an average DNA length of
500 to 1,000 base pairs. Antibodies were added to each of the samples, which were then
rotated overnight and a temperature of 4°C. After interaction with protein A beads and
incubation overnight at 65°C to reverse the cross-links, the DNA was dissolved in Tris-
EDTA buffer and then analyzed by PCR. The anti-CREB, anti-pCREB, and anti-
Sp1antibodies (Upstate Biotechnology, Inc., Waltham, MA) or normal rabbit IgG was added
separately into the reaction solutions. Primers used for PCR were obtained from CREB
promoter sequences: 5′-AAGGTCTTCGGCAAGTTCC-3′ (sense) and 5′-
TTCTCTCCCCCACGTAACAC-3′ (antisense).
RNA Interference Analyses
For knockdown by RNA interference, we used SMARTpool siRNA of CREB, RARα,
RARβ, RARγ, and RXRα (Upstate Biotechnology, Inc.). Sp1 siRNA purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Briefly, NHTBE cells at 60% to 70% confluence
were transfected with a final concentration of 100 nM SMARTpool siRNA or nonspecific
control pool (siRNA negative control) using the siIMPORTER siRNA transfection reagent
(Upstate Biotechnology, Inc.) according to the manufacturer’s instructions. Sp1 siRNA was
also transfected at 100 nM. For luciferase reporter assay, −321/−70 CREB-LUC was co-
transfected with siRNA of CREB or Sp1. After 72 h of transfection, when the target protein
levels had been reduced by 70% to 80% as assessed by western blot analysis, the cells were
treated with or without RA for another 24 h or 48 h and then assessed by the luciferase
reporter assay. Then, whole-cell lysate was prepared for western blot, QRT-PCR, RT-PCR,
and luciferase assays.
Western Blot Analyses
Western blot analysis was performed as previously described [13]. Briefly, whole-cell
extracts were prepared using 2x SDS Laemmli lysis buffer. Equal amounts of total protein
(20 μg) were resolved by 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE). We
used mouse monoclonal antibodies against β-actin (clone AC-15; Sigma-Aldrich, St. Louis,
MO), rabbit polyclonal antibodies against Sp1 (Upstate Biotechnology, Inc.), and total
CREB and phospho-CREB (Upstate Biotechnology, Inc.). Proteins reactive with primary
antibody were visualized with a horseradish peroxidase-conjugated secondary antibody and
enhanced chemiluminescence reagents (Amersham Bioscience, Arlington Heights, IL).
Statistical Analyses
For all transfection assays and QRT-PCR analysis, data were shown as mean ± SE of
triplicate assays in three independent experiments. Statistical analysis was performed using
Student’s t test (Prism;GraphPad Software, San Diego, CA), and statistical significance are
expressed as * p < 0.05, ** p < 0.01.
RESULTS
RA upregulates CREB expression in time- and dose-dependent manners
To determine whether RA regulates the CREB gene, we determined the level of CREB gene
expression before and after RA treatment. CREB mRNA and protein expression were
significantly increased by RA treatment for 1, 3 and 5 days compared to vehicle-treated
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control (Figure 1, A and B). CREB protein and mRNA also increased in a dose-dependent
manner after 24 h of RA treatment; in this analysis (Figure 1, C and D).
To further investigate the effects of RA on CREB gene regulation due to an increase of
transcription and translation, we used ActD, a general inhibitor of mRNA transcriptional
synthesis, and CHX, a general inhibitor of protein synthesis, to inhibit de novo synthesis of
mRNA and protein; NHTBE were then treated with RA. Pretreatment with either ActD or
CHX alone did not affect the endogenous level of CREB; however, RA-induced CREB
mRNA expression was completely blocked (Figure 1E). Taken together, these findings
demonstrate that RA increases CREB gene expression and that this upregulation occurred at
transcription level while de novo synthesis of protein is required.
RA-induced upregulation of CREB is independent of retinoic acid receptors
Next, we examined whether RA-induced CREB gene expression is mediated by the
conventional RA receptors (RAR and RXR). In cultured NHTBE cells, pretreatment with 10
μM Ro 61-8431 (pan-RAR antagonist) or Ro 26-5405 (pan-RXR antagonist) alone did not
affect the endogenous level of CREB. In addition, neither the pan-RAR antagonist nor the
pan-RXR antagonist could block RA-induced CREB gene expression (Figure 2A). The
activities of pan-RAR and RXR antagonists were confirmed by measuring the mRNA level
of the RAR/RXR-mediated RA target gene RARβ (Figure 2B). RA-induced RARβ mRNA
expression was almost completely blocked by either antagonist.
To further investigate the effects of RAR/RXR on RA-induced CREB gene expression, we
used RAR/RXR siRNA to suppress the endogenous expression of RAR/RXR in NHTBE
cells. Cotransfection of the NHTBE cells was done using SMARTpool-sequenced siRNA
targeting the human RAR and RXR receptors with a combination of RARα, RARβ, and
RARγ/RXRα (Figure 2C). We silenced only the α isotype of RXR because it is known that
RXRα plays a critical role in RAR/RXR heterodimers [41, 42]. We observed maximal
reduction of endogenous RAR/RXR protein 72 h after transfection. Successful suppression
of RAR/RXR has been demonstrated previously and residual RAR/RXR were not sufficient
enough to transmit RA signaling [13, 14]. Likewise, the RA-induced expressions of CREB
mRNA and protein were not significantly reduced after co-transfection with a combination
of RAR and RXR siRNAs (Figure 2, C and D), strongly indicating that RAR and RXR
receptors are not involved in RA-induced CREB regulation.
Sp1 binding sites are required for CREB promoter transactivation
To determine the key transcription factor involved in RA-induced CREB regulation, we first
generated a series of 5′ deletion constructs of human CREB promoter by subcloning
appropriate restriction fragments upstream of the luciferase gene in the pGL3-Basic
luciferase reporter vector. Then we transiently transfected them into NHTBE cells to
determine their RA-induced luciferase activities. In the current analysis (Figure 3), we found
that RA caused a 7.84-fold increase in the luciferase activity of reporter construct containing
the CREB promoter (nucleotides −2313 to −70), relative to untreated control. In addition,
RA increased luciferase activity even further, to 8.07-fold over control, in tests using a
deletion mutant of CREB promoter that contained nucleotides −260 to −70. However, the
deletion mutants that contained nucleotides from the −196 to −70 and −134 to −70 regions
of the CREB promoter significantly decreased RA-induced luciferase activity compared
with the 2.2-kb CREB promoter (nucleotides −2313 to −70); the −196/−70 and −134/−70
CREB-LUC mutants yielded increases of only 2.07-fold and 1.35-fold over control, whereas
that yielded by the −2313/−70 CREB-LUC mutant was 7.84-fold over control (p < 0.01)
(Figure 3). These results show that the region between nucleotides −260 and −134 upstream
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of the CREB coding sequence, which includes two Sp1 motifs, is critical for transactivation
of the CREB promoter by RA.
By analyzing the CREB promoter sequences in the TFSEARCH database
(http://mbs.cbrc.jp/research/db/TFSEARCH.html) at a threshold score of 74.0, we identified
two putative Sp1-binding sites (Sp1 motifs) and two putative CREB binding sites (CRE
motifs) in the −260 to −70 CREB promoter region, as shown in Figure 4A. To further
determine the role of Sp1 and CRE motifs in CREB expression, we next generated point-
mutated Sp1 and CRE motifs in the CREB promoter luciferase reporter vector and tested
their transactivation by RA (Figure 4A). We found that Sp1 mutants, as both single mutants
(Sp1-1 at −150 or Sp1-2 at −217) and as a double mutant (Sp1-1 + Sp1-2), significantly
reduced promoter activity compared with the RA-stimulated wild-type CREB promoter
(nucleotides −321 to −70)/luciferase reporter construct as a template to make a construct
with site-specific mutations; Sp1-1 alone increased activity 2.72-fold over control, Sp1-2
alone increased it 2.52-fold, and Sp1-1 + Sp1-2 increased it 1.67-fold, whereas the RA-
stimulated CREB promoter (nucleotides −321 to −70)/luciferase reporter construct
increased it 8.04-fold. Whereas neither CRE mutant alone (CRE1 mt nor CRE2 mt) affected
promoter activity, the double CRE mutant (CRE1 + CRE2 mt) slightly decreased the
promoter activity compared with the RA-stimulated CREB promoter (nucleotides −321 to
−70)/luciferase reporter construct. CRE1 alone increased promoter activity 7.14-fold over
control, CRE2 alone increased it 6.82-fold, and CRE1 + CRE2 increased it 5.92-fold. These
data clearly demonstrate that the Sp1 motifs, which surround the transcription initiation start
site, are required for RA-induced CREB promoter transactivation.
Phylogenetic analysis of CREB promoter shows conservation of CRE, Sp1 motifs in
several species
To determine the evolutionary conserved transcription factor that may play a critical role on
the regulation of the CREB gene, we analyzed the human CREB gene promoter around the
transcription start site and compared it with mouse, xenopus, and zebrafish CREB gene
promoters (Figure 5). Genomic DNA sequences of the CREB promoter region from four
different species were obtained (Ensembl genome browser, http://www.ensembl.org/) and
aligned using the NCBI blast two-sequence alignment program (bl2seq). The human CREB
promoter is enriched in the nucleotides guanosine and cytosine (65% G+C) and contains no
CAAT or TATA box motifs [43]; however, it does contain the 5′-TCCTCAGTCGG-3′
sequence, which resembles the initiator sequence 5′-PyCCTAPyTCTG-3′ that has been
shown in TATA-less promoters to initiate gene transcription at the conserved A nucleotide
[44]. The numbering was based on the translation start site, defined as +1. Because of the
lack of a TATA box, the CREB promoter is numbered relative to the translation start site,
placing the major transcription initiation start site at position −181. As Figure 5 shows, two
Sp1 motifs and CRE motifs are present within the 191-base pair promoter fragment; they are
located between nucleotides −260 and −70. Sp1 sites surround the major transcription
initiation site (at positions −217 and −150), and the two CREs are located −119 and −98
base pairs downstream of the transcription start site. The two CRE motifs are highly
conserved among the four species, but Sp1 motifs are conserved only in human and mouse.
Transcription factor Sp1 and CREB bind specifically to the CREB promoter
To determine whether Sp1 and CREB specifically bind to their binding motifs (boxes in
Figure 5) in the CREB promoter, we performed competition EMSA and ChIP assays with
anti-CREB, anti-pCREB, and anti-Sp1 antibodies. EMSA data showed that the radiolabeled
oligonucleotides of Sp1-1, Sp1-2, CRE1, and CRE2 formed DNA protein. In addition,
pretreatment with these cold oligonucleotides abolished nuclear protein binding to
radiolabeled oligonucleotides. To further confirm Sp1 and CREB binding to putative Sp1
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and CRE motifs after RA treatment, supershift assays were preformed in the presence of
anti-Sp1 or anti-CREB antibodies. After incubation of either of these antibodies, attenuation
and band shift were seen in the DNA-protein bindings (Figure 6, A and B, lanes 6 and 9).
However, normal rabbit IgG did not induce attenuation or band shift of these DNA-protein
bindings (Figure 6, A and B, lanes 5 and 8). These results indicate that Sp1 and CREB
specifically bind to Sp1- and CRE-binding motifs, respectively (Figure 6, A and B).
ChIP assay confirmed that endogeneous Sp1 and CREB bind to this promoter region (Figure
6C). One pair of primers was used to amplify the CREB promoter regions from −321 to −70
(252 base pairs), which contained the Sp1 and CRE sites. Sp1 and CREB were recruited to
the CREB promoter with or without RA treatment. However, the level of recruited CREB
and Sp1 protein was increased after 24 and 48 h of RA treatment. These results indicate that
RA increased Sp1 and phosphorylated CREB binding to the CREB promoter in vivo.
RA induces Sp1 expression
Because ChIP analysis (Figure 6C) showed that RA increases Sp1 binding to the CREB
promoter, we examined the possibility that RA is also involved in the regulation of
endogenous Sp1 in NHTBE cells. As shown in Figure 7, A and B, Sp1 protein expression
levels remained unchanged until 4 h of RA treatment and then gradually increased
thereafter. In addition, QRT-PCR revealed that Sp1 mRNA was upregulated 3.91-fold
within 1 day of RA treatment and remained elevated thereafter (Figure 7C). These results
indicate that RA treatment significantly increases Sp1 mRNA and protein compared with
control treatment. In addition, Sp1 protein and mRNA were increased in a dose-dependent
manner at 24 h of RA treatment (Figure 7, D and E).
Next, to determine whether RAR/RXR is involved in RA-induced Sp1 gene regulation, we
used the siRNA approach to deplete expression of RARα, RARβ, RARγ, and RXRα in
NHTBE cells. RA-induced expression of Sp1 mRNA was not affected after cells were co-
transfected with the combination of RAR and RXR siRNAs, implying that RAR and RXR
receptors are not involved in RA-induced Sp1 gene regulation (Figure 7F).
Both Sp1 and CREB are required for RA-induced CREB gene expression
To further investigate the roles of Sp1 and CREB on CREB gene regulation and
transactivation, we used an siRNA approach to suppress the endogenous expression of Sp1
and CREB in NHTBE cells and determined the level of RA-inducible Sp1 and CREB
protein expression. We found that RA-induced CREB protein expression was reduced after
transfection with Sp1 siRNA, whereas CREB siRNA did not affect RA-induced Sp1
expression (Figure 8A). Furthermore, RT-PCR analysis demonstrated that the decrease in
endogenous CREB mRNA was dependent on Sp1 silencing, whereas CREB siRNA did not
affect RA-induced Sp1 mRNA expression (Figure 8B). This result shows that Sp1 is
important for CREB gene expression.
Next, to further determine the role of Sp1 and CREB on RA-induced transactivation of
CREB promoter activity, we co-transfected pGL3-Basic luciferase reporter vector
containing CREB promoter (nucleotides −321 to −70) region and Sp1 siRNA or CREB
siRNA. Using a luciferase activity assay, we found that knockdown of either endogenous
Sp1 or endogenous CREB significantly decreased RA-inducible CREB gene transactivation
(Figure 8C). Sp1 knockdown decreased the CREB promoter activity significantly more than
CREB knockdown did, (82.9% versus 69.1%), compared with RA-treated nontransfected
control. These results strongly support both Sp1 and CREB are required for RA-induced
transactivation of CREB promoter activity.
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Moreover, these data suggest that Sp1 has a more important role than CREB in RA-
inducible CREB gene regulation and that Sp1 and CREB may interact and/or that these
protein interactions dependently or independently support binding to the imperfect CRE or
Sp1 motifs to facilitate transcription from the CREB promoter.
DISCUSSION
Earlier studies have shown that RA deficiency induced metaplastic squamous differentiation
in airway mucosa and normal mucociliary phenotype can be restored by RA treatment [5,9].
Our recent study showed that one of the earliest event occurred during this restoration of
normal mucous phenotype from squamous metaplasia involved in CREB activated by RA.
In the present study, we found that RA not only activated CREB but also induced expression
of CREB gene in bronchial epithelial cell and that Sp1 played an important role in the
upregulation of the CREB gene expression during mucous differentiation of normal human
bronchial epithelial cells. By conducting a detailed analysis of the promoter of CREB in
order to gain an understanding of the molecular mechanisms associated with the
upregulation of CREB transcription in response to RA, we found that Sp1 and CRE motifs
in the essential promoter region of the CREB were required for full transcriptional activity in
the RA-induced transcription of the human CREB gene. These RA-inducible CREB gene
up-regulation mechanisms appeared to be mainly controlled by binding of the two Sp1
binding motifs in the essential promoter region to Sp1, which is also upregulated by RA.
Our studies showed that the two Sp1-binding motifs near the upstream of the transcription
start site have a major role in CREB gene regulation. Other investigators have also shown
that transient overexpression of Sp1 significantly induces CREB promoter activity in
Drosophila SL2 cells, suggesting that Sp1 is a potent activator of CREB gene expression
[45]. Mutation of the downstream Sp1 motif (Sp1-1 mt) in the CREB promoter resulted in a
50% decrease in basal activity in Sertoli cells. However, mutation of the Sp1 site, which is
located upstream of the transcription initiation site (Sp1-2 mt), did not affect CREB
promoter activity [37]. However, Coven et al. [46] report that only one of the Sp1 site
(Sp1-2) were required for the normal upregulation of CREB promoter activity in C6 cells. In
this study, we also showed that the RA-inducible essential promoter region was located in
the nucleotide −260 to −70 segment of the CREB promoter region (Figure 3). Tests for
mutagenesis in two putative Sp1-binding motifs and two CRE motifs showed that alone,
neither the CRE-1 mt nor the CRE-2 mt affected promoter activity; however, the double
CRE mutant (CRE1 mt + CRE2 mt) slightly decreased RA-inducible CREB promoter
activity. The Sp1-1 and Sp1-2 mutants alone and combined (Sp1-1 mt + Sp1-2 mt)
significantly reduced RA-inducible promoter activity compared with wild-type CREB
promoter (Figure 4). Our results strongly suggest that two CRE motifs bind CREB, which
contributes to basal promoter activity, and that two Sp1-binding motifs bind Sp1, which is
essential for RA upregulation of CREB gene transcription. .
In contrast to our findings, Walker et al. [37] reported that the presence of three CRE-like
sequences in the first 1,240 base pairs upstream of the translation start site in the CREB
promoter region suggested regulation of the cAMP-inducible CREB gene expression
pathway. They showed that cAMP-inducible CREB gene expression required the two CREs
located downstream of the major transcription start site in the CREB gene promoter. They
also showed that only Sp1-1 binding sites contributed to basal promoter activity. In neuronal
cells, up- or down-regulation of CREB expression by activation of the cAMP pathway has
been reported both in vivo and in vitro [32,34,35]. Activation of the cAMP pathway resulted
in downregulation of CREB mRNA and protein in CATA.a cells (a neural-derived cell line)
[47], whereas the same treatments did not alter CREB expression in PC12
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pheochromocytoma cells [34]. These findings imply that regulation of CREB expression by
the cAMP pathway depends on specific cell type.
The results of our EMSA and ChIP analyses further support the belief that Sp1 binds
specifically to the Sp1-binding motif and that CREB binds specifically to CRE motifs, in
vitro and in vivo (Figure 6). These results also suggest that the Sp1-1, Sp1-2, CRE1, and
CRE2-binding motifs in this promoter region can function in vivo. Our finding that Sp1 and
CREB binding on the CREB promoter region was increased after 24 h of RA treatment
suggests that both the RA-induced upregulated Sp1 and phosphorylated CREB may have a
role in upregulating the CREB gene expression during the early stages of epithelial cell
differentiation (Figure 6C). It has been reported that the promoter region of human and
mouse CREB has three variant CREs spread over nearly 800 base pairs [31,48]. These CREs
are highly conserved in organisms ranging from zebrafish to humans; however, Sp1-binding
motifs are conserved only in mice and humans (Figure 5). Thus, both Sp1- and CRE-binding
motifs might have important roles in CREB gene regulation in many organisms. As shown
in Figure 5, the transcription start sites are located in different regions of the promoter
region in humans and mice, implying that different transcription regulation mechanisms
exist in the two species.
It has also been reported that nuclear factor (NF)-κB and tumor necrosis factor (TNF)-α are
regulators of CREB expression. Delfino and Walker [49] showed that overexpressed NF-κB
interacts with the NF-κB-binding site in the CREB promoter and increases promoter activity
in Sertoli and NIH 3T3 cells. These results suggest that NF-κB may be an important
regulator of the genes required for spermatogenesis and a general regulator of CREB gene
expression in nontestis cells. However, our reporter assay indicates that RA-induced CREB
activity was retained by luciferase vector containing CREB promoter region from
nucleotides −447 to −70, from which the putative NF-κB-binding sites had been deleted
(Figure 3). We therefore postulate that NF-κB is not required for RA-inducible CREB
expression in NHTBE cells.
RA reportedly has a profound effect on the regulation of cell growth and differentiation,
primarily through two families of nuclear receptors: RARs and RXRs. Several studies have
shown that RARs and RXRs, upon binding to ligands, promote transcription through
interaction with co-activators [50,51]. However, our data suggest that RA upregulates CREB
independently of RAR and RXR because NHTBE cells depleted of RARs and RXRα by
means of siRNAs targeting RARα, RARβ, RARγ, and RXRα could still mediate RA-
induced transactivation of CREB promoter activity. In addition, in our study, selective pan-
RAR and pan-RXR antagonists did not block RA activation of CREB (Figure 2). We
previously reported that RA rapidly induced CREB activation via a nonclassical RA-
signaling mechanism without using its canonical RARs and RXR [13]. All these results
strongly suggest that the activation and regulation of the CREB gene by RA are both RAR
and RXR independent.
We also showed that RA upregulated Sp1 gene expression in time- and dose-dependent
manners (Figure 7A–7E). Interestingly, our data suggest that RA-inducible Sp1 gene
upregulation is independent of RAR and RXR function: depletion of RARs/RXRα using
siRNA did not affect the RA-induced transactivation of Sp1 promoter activity. However,
further extensive studies are required to determine how RA upregulates Sp1 expression
without using its conventional receptors, RAR/RXR. Notably, our data showed that
endogenous depletion of Sp1 significantly reduced the RA-inducible CREB gene but that
CREB depletion did not affect Sp1 gene upregulation (Figure 8). In addition, Sp1 depletion
completely abolished RA-inducible CREB promoter activity (to a level only 1.2-fold higher
than that of untreated controls), and CREB depletion significantly abolished the CREB
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promoter activity. Our results strongly suggest that Sp1 has a more critical role than CREB
in RA-inducible CREB gene regulation and that these two proteins facilitate the binding of
imperfect CRE and Sp1 motifs to each other. It is plausible that a basal level of CREB is
positively auto-regulated by RA-activated CREB. In addition, Sp1 protein, which is
increased by RA, binds to two Sp1-binding sites in the CREB promoter region to further
facilitate transactivation of CREB genes in early stage of NHTBE cells differentiation.
In summary, our findings further demonstrates that RA upregulates CREB gene expression
during the early stage of NHTBE cell differentiation and that RA-inducible Sp1 plays a
major role in upregulating human CREB gene expression. This finding and our earlier
findings suggest that several transcription factors, including CREB, Sp1, and RAR/RXR
may coordinately regulate differentiation program of bronchial epithelial cells. CREB and
Sp1 may play an important role in preparing environment for mucous cell differentiation
when the level of RAR/RXR is not sufficient in the cells, such as in squamous metaplasia
state.
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ATF1 activating transcription factor 1
BAC bacterial artificial chromosome
bZip basic domain-leucine zipper
cAMP Cyclic 3′,5′-adenosine monophosphate
ChIP chromatin immunoprecipitation
CHX cycloheximide
CBP CREB-binding protein
CRE cAMP response-element
CREB CRE binding protein
CREM CRE modulator
EMSA electrophoretic mobility shift assays
GAPDH glyceraldehyde-3-phosphate dehydrogenase
NHTBE normal human tracheobronchial epithelial
NF-κB nuclear factor-κB
NRs nuclear receptors
RA retinoic acid
RAR RA receptor
RXR retinoid X receptor
siRNA small interfering RNA
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TNF-α tumor necrosis factor-α
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Figure 1.
RA upregulates CREB expression. (A–E) NHTBE cells grown in RA-deficient medium for
7 days were incubated with or without 1 μM RA for various periods of time or with various
concentrations of RA for 24 h, as indicated on the figure panels. CREB expression was
analyzed by western blotting (A and C) and QRT-PCR (B and D). Vehicle (DMSO) was
used as negative controls, respectively. (E) ActD and CHX effects on RA-induced CREB
expression. NHTBE cells were pre-incubated in the presence or absence of 5 μg/ml ActD or
10 μg/ml CHX for 2 h and were either left untreated or treated with 1 μM RA for 24 h.
CREB mRNA expression levels were measured by QRT-PCR. In panels A and C, the
western blots are representative of those from three repeat experiments. In panels B, D, and
E the data represent the mean ± SE of three independent experiments, each performed in
triplicate. * p < 0.05, ** p < 0.01 compared with untreated control. † p < 0.05 compared
with the RA-treated group.
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Figure 2.
RAR and RXR receptor independent effect on RA-induced CREB regulation. (A and B)
NHTBE cells grown in RA-deficient medium for 7 days were preincubated with or without
pan-RAR or pan-RXR antagonist (10 μM) for 2 h and then further incubated with RA (1
μM) for 48 h. Vehicle (DMSO) was used as a negative control. (A) QRT-PCR analysis of
CREB mRNA expression normalized to GAPDH endogenous control. Data represent the
mean ± SE of three independent experiments, each performed in triplicate. * p < 0.05
compared with RA-untreated control. (B) To show the effects of pan-RAR antagonist and
pan-RXR antagonist, RARβ mRNA expression was measured by RT-PCR. After treatment,
total RNA was extracted and then used to measure the RARβ mRNA level. RT-PCR
products were analyzed on a 2% agarose gel using β-actin as a loading control. (C) Effects
of siRNA knockdown of RAR/RXR on CREB regulation. NHTBE cells were transiently
transfected with siRNAs of RAR and RXR together in combination with either siRNA-
Rαβγ/Xα or a nonspecific control pool (NS siRNA). Three days after transfection, the cells
were further incubated with or without RA for 24 h. After treatment, CREB mRNA
expression was measured by QRT-PCR and the results normalized to those for GAPDH
endogenous control. To show the effects of RAR/RXR siRNA, RARβ expression was
measured by western blotting. Equal loading was confirmed by stripping the blot and
reprobing it for β-actin antibody. Results are representative of those from three independent
experiments. * p < 0.01 compared with the untreated control.
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Figure 3.
Functional deletion analysis of the human CREB promoter region. The diagram represents
the locations of the Sp1 and CRE motifs and the numbers on the left side represent the
upstream start site of the CREB promoter region. NHTBE cells were transiently transfected
with serially deleted CREB promoter containing luciferase reporter constructs and then
treated with RA. After 48 h of transfection, cell extracts were assayed for luciferase activity,
which was normalized to renilla luciferase activity, as described in Materials and Methods.
The data are expressed relative to the basal activity of the CREB promoter (indicated as
−2313/−70 CREB-LUC = 100%) and represent the mean± SE of three independent
experiments, each performed in triplicate. The asterisk indicates the difference from the RA-
stimulated −2313/−70 CREB-LUC construct (* p < 0.01). The numbers on the left side of
the diagram represent the start position of the 5′ location on the CREB promoter region.
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Figure 4.
Analysis of mutated Sp1 and CRE motifs in the CREB promoter. (A) The schematic
diagram represents the locations and sequences of the wild-type (wt) and mutated (mt) Sp1
and CRE motifs. (B) NHTBE cells were transiently transfected with various mutants of Sp1
and CRE in the CREB promoter–luciferase reporter constructs. The diagrams show the
relative locations of the Sp1 and CRE motifs in the −321 to −70 CREB-LUC construct. An
X in a motif designates a mutation. After transfection, the cells were further incubated with
1 μM RA or vehicle control for 48 h. The data are expressed relative to the fold increase in
luciferase acitivity over untreated control and represent the means ± SE of three independent
experiments, each performed in triplicate. The asterisk indicates the difference from the RA-
stimulated wild-type −321/−70 CREB-LUC construct (* p < 0.05, ** p < 0.01).
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Figure 5.
Alignment of the nucleotide sequences around the transcription initiation sites of CREB
genes from four different species. The respective transcription initiation sites are indicated
by the solid dot (●). Gaps in the sequence are indicated by dashes, and nucleotide numbers
are shown for the human sequence. The positions of sequence identity are also indicated (*).
The previously known sequence elements, including Sp1 and CRE sequences, are boxed.
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Figure 6.
The effect of RA on CREB promoter binding of Sp1 and CREB. (A and B) EMSA was
performed using NHTBE cells that were cultured for 7 days with or without RA and then
treated with RA for 24 h. Ten micrograms of nuclear extract was prepared, and DNA-
protein binding activity was measured by EMSA using various [γ-32P]ATP-labeled
oligonucleotides corresponding to Sp1-1, Sp1-2, CRE1, and CRE2, as described in Materials
and Methods. The DNA-binding reaction was performed in the absence or presence of a
100-fold excess of each oligonucleotide unlabeled (that is, an unlabeled competitor).
Supershift assays were performed using 2 μg of the anti-CREB and anti-Sp1 antibodies, as
indicated above each lane in panels A and B. The labeled nucleotide and nuclear protein
complexes were separated by electrophoresis on 5% polyacrylamide gels, and the gels were
dried and autoradiographed at −80°C. The asterisks (*) indicate shifted bands. (C) ChIP
analysis was performed using NHTBE cells grown in RA-deficient medium for 7 days. The
cells then were incubated with or without 1 μM RA for the indicated time. ChIP assays were
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performed using anti-phospho-CREB (pCREB), anti-CREB, or anti-Sp1 antibodies to
precipitate CREB promoter that corresponded to the position −321/−70 region. One percent
of the chromatin was assayed to verify equal loading (Input), and nonspecific IgG was
assayed under otherwise identical conditions as a negative control. Results are representative
of those from three independent experiments.
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Figure 7.
RA increases Sp1 expression. NHTBE cells were grown in RA-deficient medium for 7 days
and then incubated with or without 1 μM RA for the indicated periods of time or with
various concentrations of RA for 24 h. Vehicle (DMSO) was used as a negative control. Sp1
gene expression was analyzed using western blotting (A, B, and D) and QRT-PCR (C and
E), as described in Figure 1. (F) NHTBE cells were transiently transfected with siRNAs of
RARs and RXR together or with nonspecific siRNA as described in Figure 2. Three days
after transfection, the cells were further incubated with or without RA for 24 h. After
treatment, Sp1 mRNA expression was measured by QRT-PCR. In panels C, E, and F, the
data represent the mean ± SE of three independent experiments, each performed in triplicate.
* p < 0.05, ** p < 0.01 compared with untreated control. † p < 0.01 compared with the RA-
treated group. In panels A, B, and D, western blot results are representative of those from
three repeat experiments.
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Figure 8.
Effect of siRNA knockdown of Sp1 on CREB gene expression. (A and B) NHTBE cells
were transiently transfected with CREB siRNA or Sp1 siRNA. A nonspecific siRNA pool
(NS siRNA) was used as the control. Three days after transfection, the cells were further
incubated with or without RA for 24 h. After treatment, CREB expression was analyzed by
western blotting (A) and QRT-PCR (B). (C) NHTBE cells were cotransfected with
−321/−70 CREB-LUC construct plasmid and CREB siRNA or Sp1 siRNA. Three days after
transfection, the cells were further incubated with or without RA for 48 h. The luciferase
activity was determined as described in Figure 3. The data are expressed relative to the basal
activity of the CREB promoter (indicated as −321/−70 CREB-LUC = 100%) and as means±
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SE of three independent experiments, each performed in triplicate. * p < 0.01 compared with
untreated control. † p < 0.01 compared with the RA-treated group.
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Figure 9.
A proposed model explaining upregulation of CREB expression by RA in NHTBE cells. In
this model, RA rapidly activates protein kinase C and transmits an activation signal to
phosphorylate nuclear CREB via the Ras/ERK/Rsk pathway, thereby increasing its
transactivation activity. A basal CREB regulation of the positive feedback loop is
constituted by induction of CREB, which is consequently activated by RA binding of CRE
motifs. In addition, Sp1 protein, which is increased by RA, binds to Sp1-binding sites in the
CREB promoter region to further activate transcription of CREB genes.
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